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stx2 genes from 138 Shiga toxin-producing Escherichia coli (STEC) isolates, of which 127 were of bovine 
origin (58 serotypes) and 11 of human origin (one serotype; O113:H21), were subtyped. The bovine STEC 
isolates from Australian cattle carried ehxA and/or eaeA and predominantly possessed stx2-EDL933 (103 
of 127; 81.1%) either in combination with stx2vhb (32 of 127; 25.2%) or on its own (52 of 127; 40.4%). Of 
22 (90.9%) bovine isolates of serotype O113:H21, a serotype increasingly recovered from patients with 
hemolytic uremic syndrome (HUS) or hemorrhagic colitis, 20 contained both stx2-EDL933 and stx2vhb; 2 
isolates contained stx2vhb only. Although 7 of 11 (63.6%) human O113:H21 isolates associated with 
diarrhea possessed stx2-EDL933, the remaining 4 isolates possessed a combination of stx2-EDL933 and 
stx2vhb. Three of the four were from separate sporadic cases of HUS, and one was from an unknown 
source. 
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stx2 genes from 138 Shiga toxin-producing Escherichia coli (STEC) isolates, of which 127 were of bovine origin
(58 serotypes) and 11 of human origin (one serotype; O113:H21), were subtyped. The bovine STEC isolates
from Australian cattle carried ehxA and/or eaeA and predominantly possessed stx2-EDL933 (103 of 127; 81.1%)
either in combination with stx2vhb (32 of 127; 25.2%) or on its own (52 of 127; 40.4%). Of 22 (90.9%) bovine
isolates of serotype O113:H21, a serotype increasingly recovered from patients with hemolytic uremic syndrome
(HUS) or hemorrhagic colitis, 20 contained both stx2-EDL933 and stx2vhb; 2 isolates contained stx2vhb only.
Although 7 of 11 (63.6%) human O113:H21 isolates associated with diarrhea possessed stx2-EDL933, the
remaining 4 isolates possessed a combination of stx2-EDL933 and stx2vhb. Three of the four were from separate
sporadic cases of HUS, and one was from an unknown source.
Shiga toxin-producing Escherichia coli (STEC) is commonly
carried by ruminants (especially cattle) and is an important
enteropathogen, causing human diseases ranging from mild
diarrhea to more severe conditions such as hemorrhagic colitis
(HC) and hemolytic uremic syndrome (HUS) (7, 15, 22a, 25,
28, 47). Although over 150 serotypes of STEC have been as-
sociated with human disease (12, 20), serotype O157:H7 is
believed to be responsible for the majority of outbreaks and
sporadic cases of HUS in the United States, Japan, and Eu-
rope. However, non-O157 STEC is of greater significance in
Australia (16) and Argentina (35), and its role in HUS and HC
in the United States and Europe is gaining recognition (24).
The most critical factors of STEC associated with severe
human disease are the Shiga toxins. STEC can produce one or
both of these groups of toxins which comprise two immuno-
logically non-cross-reactive groups (designated Stx1 and Stx2),
although other virulence factors such as intimin and enterohe-
molysin either directly contribute to (or are implicated by
association with) the pathogenicity of STEC (11, 21).
stx2 comprises 11 distinct variants (5, 19, 23, 31, 38, 39, 42,
45, 46, 50) and is considered the most important STEC viru-
lence factor associated with human disease (11, 21, 34, 41).
More importantly, differences in the degree of pathogenicity of
STEC serotypes have been associated with variations in the stx2
subtype (27, 29, 30, 42). The most frequently reported stx2
subtypes are represented by stx2c, stx2d, and stx2e (42, 46, 50).
Although more than 200 different O:H serotypes of STEC
have been isolated from cattle (1, 7, 12, 20, 24, 49, 51), there is
a paucity of information regarding associations between sero-
type, stx2 subtype, and virulence factor profiles among STEC
isolates from meat-producing animals (9, 10, 22a, 26, 33, 43).
stx2 subtypes stx2-EDL933 and stx2c (stx2vha and stx2vhb) have
been described in European studies of bovine STEC; however,
their association with serotype has not been reported previ-
ously (8, 42, 46). Ramachandran et al. (44) demonstrated that
stx2-containing STEC from ovine feces usually belonged to the
stx2d subtypes (stx2d-Ount/O111/OX3a).
The purpose of this study was to subtype stx2 genes among a
serologically diverse collection of 138 stx2-containing STEC
isolates primarily derived from bovine feces collected from the
eastern states of Australia and to compare stx2 subtypes of
STEC isolates of serotype O113:H21 (an important serotype
increasingly associated with HUS and HC in humans) of bo-
vine and human origin.
A total of 138 STEC isolates, of which 134 were non-O157,
were used in this study. These consisted of 127 isolates from
cattle and 11 human isolates from individual cases of clinical
infections (Table 1). All isolates were prepared and subjected
to multiplex PCR for the detection of STEC virulence factors
stx1, stx2, ehxA, and eaeA as described previously (14). Ampli-
fied PCR products were then resolved by gel electrophoresis
through agarose (2% wt/vol) and stained with ethidium bro-
mide (5 l/ml). Visualization was undertaken using UV illu-
mination, and images were captured using a GelDoc 1000
image analysis station (Bio-Rad).
Bovine STEC isolates with stx2 were subjected to subtyping
using typing schemes previously reported (4, 42, 48). For this
study, stx2d subtypes are defined as nucleotide sequence vari-
ants of stx2 (stx2d-Ount, stx2d-O111, and stx2d-OX3a), as described
previously (42), and are not the potentially mucin-activatable
stx2d variants described by Melton-Celsa et al. (30) (defined as
stx2vha and stx2vhb in this study). stx2 genes amplified with
VT2-e and VT2-f primers and Lin F and Lin R primers were
subjected to restriction fragment length polymorphism
(RFLP) analysis with the enzymes HaeIII and PvuII (42) and
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TABLE 1. Virulence factor profiles and stx2 subtypes of STEC of bovine and human origin
Source Serotype
No. of
isolates
of animal
or human
origin
Virulence factor No. of isolates containing stx2 variant(s)
stx1 stx2 ehxA eaeA stx2-EDL.933 stx2vhb stx2d-Ount
stx2-EDL933/
stx2vhb
stx2-EDL933/
stx2vhb/stx1
stx2vhb/stx1
stx2-EDL933/
stx1
stx2d-OX3a
Ba O2:H8 1     1
B O3:H7 2     1 1
B O5:H 2     2
B O5:H7 2     1 1
B O6:H8 1     1
B O6:H28 1     1
B O6:H34 3     3
B O8(KA):H51 1     1
B O8:H16 1     1
B O8:H19 6     6
BDb O21:H21 1     1
B O28:H8 3     3
B, BD O28:H40 2     2
B O49:H 1     1
B O53:H2 1     1
B O76:H7 1     1
B O81:H21 1     1
B O82:H8 5     1 4
B O82:H40 2     2
B O91:H 1     1
B O91:H21 1     1
B O93:H19 1     1
B O104:H7 1     1
B O108:H7 2     2
B O110:H40 1     1
B O111:H 1     1
B O111:H 1     1
BD O111:H8 1     1
BD O113:H 1     1
B BD O113:H21 20     20
B O113:H21 2     2
Hc (HUS, HAd) O113:H21 3     3
H (Diarrhea, HUS) O113:H21 6     6
H (?) O113:H21 1     1
H (?) O113:H21 1     1
B O116:H21 1     1
B O130:H11 1     1
B O130:H11 6     6
B O130:H38 2     2
B O141:H49 1     1
B O153:H8 1     1
B O153:HR 2     2
B, BD O157:H8 2     2
B O157:H 1     1
B O157:H7 1     1
B O163:H 1     1
B O163:H19 1     1
B O163:H19 1     1
B Ont:H2 2     2
B Ont:H5 1     1
B Ont:H7 2     1 1
B Ont:H8 1     1
B Ont:H8 3     3
B Ont:H11 2     1 1
B Ont:H11 2     2
BD Ont:H11 1     1
B Ont:H16 1     1
B Ont:H21 1     1
B Ont:H28 1     1
B Ont:H28 1     1
B Ont:H30 1     1
B Ont:H41 1     1
B Ont:H49 3     2 1
B Ont:H49 1     1
B Ont:HR 1     1
Continued on following page
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the enzymes HincII and AccI (28), respectively. In circum-
stances in which a stx2 gene could not be reliably subtyped
using the above-described approach, the gene was amplified
with Tyler F and Tyler R primers and subjected to RFLP
analysis with the enzymes MspI, NciI, and RsaI (Table 2) (48).
PCR products were digested for a minimum of 4 h at 37°C.
Fragments were separated by electrophoresis through agarose
gels (2% wt/vol), and subtypes were determined according to
comparison with profiles reported previously (4, 42, 48).
DNA sequence analysis of both the A and B subunits of two
stx2-containing STEC isolates with serotype O110:H40 and
Ont:H11 were undertaken, since RFLP analyses confirmed
these isolates possessed stx2 subtypes representative of the
majority of the collection. stx2 was amplified using 10 pmol of
each of the oligonucleotide primers Stx2F and Stx2R (Table 3).
PCRs (50 l) were carried out containing 2 l of nucleic acid
of a crude whole-cell DNA template prepared using Instagene
matrix as described previously (17), 10 mM Tris-HCl (pH 8.3),
10 mM KCl, 2 mM MgCl2, 200 M each deoxynucleoside
triphosphate, and 1 U of Taq DNA polymerase.
Thermocycler steps involved an initial denaturation step
(95°C for 5 min) followed by 35 cycles of denaturation (95°C
for 30 s), annealing (60°C for 45 s), and extension (72°C for
90 s). A final extension step of 72°C for 5 min completed the
PCR. The amplified PCR product was separated by 2% aga-
rose gel electrophoresis. For DNA sequencing, PCR amplifi-
cation products were purified using a QIAquick DNA purifi-
cation kit (Qiagen, Hilden, Germany). Sequencing reactions
were performed using the Big Dye terminator cycle sequencing
ready reaction DNA sequencing kit and electrophoresed on an
ABI prism 377 DNA sequencer (Perkin Elmer, Foster City,
Calif.) as described previously (44). Auto Assembler software
(Perkin Elmer) was used to compile and analyze the DNA
sequences. Nucleotide and amino acid analysis was performed
using programs accessed via the Australian National Genomic
Information Service (www.angis.org.au). Sequences were com-
pared with those deposited in public databases using the
BlastN and BlastP algorithms (2).
All 138 isolates possessed stx2 and comprised 58 serotypes.
STEC serotypes and their virulence factor profiles are listed in
Table 1. A significant proportion of bovine STEC isolates (32
of 127; 25.2%) possessed more than one stx2 variant or a
combination of an stx2 variant(s) together with stx1 (35 of 127;
27.6%). Isolates with two copies of stx2 were shown to possess
stx2-EDL933 and stx2vhb (31 of 127; 24.4%) (Table 1). STEC
isolates possessing stx2-EDL933 alone were also prevalent (59 of
138; 42.8%). These 59 isolates belonged to 28 serotypes (Table
4). Isolates with stx2-EDL933 and stx1 comprised the third most
common group (19 of 138; 13.7%), representing 13 serotypes,
followed by stx2vhb and stx1 (11 of 138; 7.9%), comprising 9
serotypes. STEC possessing the three Shiga toxin factors
stx2-EDL933, stx2vhb, and stx1 was identified with a frequency of
5 of 138 (3.6%) and was represented by 5 serotypes (Table 4).
STEC containing stx2vhb alone (8 of 138; 5.8%), stx2d-Ount (2 of
138; 1.4%), or stx2d-OX3a (3 of 138; 2.2%) was isolated infre-
quently (Table 4). Two bovine isolates of the serotype O5:H,
a serotype commonly recovered from ovine feces (14), pos-
sessed an stx2d-OX3a subtype; this subtype is commonly associ-
TABLE 1—Continued
Source Serotype
No. of
isolates
of animal
or human
origin
Virulence factor No. of isolates containing stx2 variant(s)
stx1 stx2 ehxA eaeA stx2-EDL.933 stx2vhb stx2d-Ount
stx2-EDL933/
stx2vhb
stx2-EDL933/
stx2vhb/stx1
stx2vhb/stx1
stx2-EDL933/
stx1
stx2d-OX3a
B OR:H 1     1
B OR:H3 1     1
B OR:H8 1     1
B OX3:H8 5     5
B OX3:H8 1     1
B OX3:H21 1     1
B OX3:H40 1     1
Total 138 59 8 2 31 5 11 19 3
a B, feces from healthy cattle unless otherwise specified.
b BD, diagnostic fecal samples from cattle.
c H, human feces.
d HA, hemolytic anemia.
TABLE 2. Restriction fragment sizes used for analysis of stx2
Primers used to
amplify fragment
Restriction
enzyme
Expected fragment size(s) for:
Reference
stx2-EDL933 stx2vhb stx2d-Ount stx2d-OX3
VT2-e, VT2-f HaeIII 348 216, 132 216, 132 167, 132, 49a 42
PvuII 323, 25a 250, 73, 25a 200, 120, 28a 200, 120, 28a
Lin F, Lin R HincII 555, 262, 62 555, 340 880, 15a 880, 15 28
AccI 544, 351 544, 351 906 544, 351
Tyler F, Tyler R MspI 232, 48a 108, 73, 51a 155, 125 48
NciI 385 159, 126
RsaI 216, 69 216, 69
a Fragment too small to visualize under the electrophoresis conditions used.
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ated with ovine STEC (44). Representative RFLP profiles pro-
duced by the digestion of PCR amplification products spanning
different regions of stx2 are depicted in Fig. 1 and 2. DNA
sequence analysis of stx2 derived from STEC serotype O110:
H40 showed 99.8% sequence identity with sequences of
stx2-EDL933 (accession number Z37725.1) (36) and the p gene
derived from phage 933W (13). The two nucleotide polymor-
phisms that differentiated the stx2 sequence of O110:H40 with
stx2-EDL933 did not alter the predicted amino acid sequence.
The stx2 gene from an O110:H40 isolate was selected for DNA
sequence analysis, because PCR-RFLP analysis indicated that
it was indicative of stx2 genes representative of the majority of
bovine isolates used in this study (Fig. 1, lane 6). DNA se-
quence analysis of the stx2 gene amplified from the Ont:H11
isolate showed 99.5% (5 nucleotide polymorphisms in the A
subunit) sequence identity with stx2vhb, a sequence variant of
stx2c (accession number X61283.1) (31). These data concur
with the results of PCR-RFLP analyses used to type stx2 vari-
ants in this study. Of the five nucleotide polymorphisms iden-
tified in the A-subunit sequence, only two polymorphisms re-
sulted in a change in the amino acid sequence. The B subunit
of stx2vhb in Ont:H11 showed nucleotide and predicted amino
TABLE 3. Primer pairs used to amplify stx2
Primer Sequence (5 to 3) Size of fragment (bp) Reference
stx2 typing
VT2-e AATACATTATGGGAAAGTAATA 348 42VT2-f TAAACTGCACTTCAGCAAAT
Lin F GAACGAAATAATTTATATGT 900a 28Lin R TTTGATTGTTACAGTCAT
Tyler F AAGAAGATGTTTATGGCGGT 285 48Tyler R CACGAATCAGGTTATGCCTC
stx2 sequencing
StxF TATCTGCGCCGGGTCT 1,280 44StxR CAAAKCCKGARCCTGA
Gannon F CCATGACAACGGACAGCAGTT 779 18Gannon R CCTGTCAACTGAGCAGCACTTTG
Paton F GGCACTGTCTGAAACTGCTCC 255 37Paton R TCGCCAGTTATCTGACATTCTG
ST F AATGCAATGGCGG 200 This studyStx2R CAAATCCGGAGCCTGC
Stx2F2 AATCCAGTACAACGCGCCA 600 This studyST R AACGCAGAACTGCTCT
Tyler F AAGAAGATGTTTATGGCGGT 285 48Tyler R CACGAATCAGGTTATGCCTC
KBStx2F AATCCAGTACAACGCGCC 395 This studyKBStx2R TTGCTGAATAATCAGACG
a Amplicons differ by a few nucleotides depending on the variant.
TABLE 4. stx2 variant(s) and association with serotype
stx2 variant(s)
No. (%) of
isolatesa Serotypes
stx2-EDL933 59 (42.8) O6:H34, O8:(KA):H51, O8:H19, O21:H21, O28:H8, O28:H40, O53:H2, O76:H7, O81:H21, O93:H19,
O104:H7, O113:H21, O116:H21, O130:H11, O141:H49, O157:H8, O163:H19, Ont:H2, Ont:H5,
Ont:H7, Ont:H8, Ont:H28, Ont:H49, Ont:HR, OR:H3, OX3:H8, OX3:H21, OX3:H40
stx2-EDL933/stx2vhb 31 (32.6) O6:H8, O6:H28, O49:H
, O113:H, O113:H21, Ont:H7, Ont:H49, OR:H8
stx2-EDL933/stx1 19 (10.4) O5:H7, O82:H8, O82:H40, O110:H40, O111:H
, O111:H8, O103:H11, O153:HR, Ont:H11,
ONT:H21, Ont:H28, Ont:H30, Ont:H41
stx2vhb/stx1 11 (8.0) O3:H7, O5:H7, O108:H7, O130:H38, O157:H
, O163:H19, Ont:H8, Ont:H11, OX3:8
stx2vhb 8 (5.8) O2:H8, O113:H21, O157:H7, Ont:H11, OR:H

stx2-EDL933/stx2vhb/stx1 5 (3.6) O3:H7, O8:H16, O82:H8, O163:H
, Ont:H16
stx2d-OX3a 3 (2.2) O5:H
, O91:H21
stx2d-Ount 2 (1.4) O91:H
, O153:H8
a Values are numbers and percentages compared to a total of 138 isolates.
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acid sequences identical to those of stx2vhb (accession number
X61283.1) (31).
In this study, we determined the stx2 subtypes of 127 bovine
STEC isolates belonging to 58 serotypes and showed that Aus-
tralian bovine STEC which also possesses ehxA and/or eaeA
predominantly possesses either stx2-EDL933 or stx2vhb subtypes
(alone or in combination with one another). We also demon-
strated that several serotypes, particularly O113:H21, simulta-
neously possess both these subtypes.
In a recent study of 167 stx2-containing STEC isolates from
healthy cattle in France, stx2vhb, stx2-EDL933, and stx2vha sub-
types were commonly identified (5). Our study identified
stx2-EDL933 and stx2vhb as the predominant subtypes (122 of
127; 96.1%) among Australian bovine STEC isolates; stx2vha-
positive STEC isolates were not observed among any of STEC
isolates in our study. Although the serotypes belonging to the
stx2-containing STEC isolates from France were not reported
(5), a recent study of 186 STEC isolates from cattle during a
1-year study in France (43) showed that few isolates possessed
serotypes in common with those identified in this study. Our
data suggest that stx2vha-positive STEC belongs to serotypes
not commonly found in Australian cattle. Alternatively, stx2vha
may only be found in STEC isolates that lack the accessory
virulence factors ehxA and/or eaeA (termed complex STEC
[22]), since all but 4 of the 138 STEC isolates in this study
possessed one or both of these factors. In support of the latter
hypothesis, the study by Bertin et al. (5) identified enterohe-
molysin among STEC isolates harboring stx2-EDL933 (78%) or a
combination of stx2-EDL933 and stx2vhb (85%); only 6 of 43
(14%) stx2vha-containing isolates also possessed ehxA, and the
presence of eaeA was not reported. Furthermore, recent stud-
ies in our laboratories have identified stx2vha-containing STEC
in isolates that do not possess ehxA and/or eaeA (our unpub-
lished data). STEC isolates simultaneously containing three
stx2 variants were not observed among the 138 Australian
STEC isolates, unlike the results reported by Bertin et al. (5).
Furthermore, the untypeable stx2 variant (identified as
stx2-NV206) which comprised 24 of 167 (14.4%) of isolates in the
study by Bertin et al. (5) was not observed in our Australian
collection; 25% of STEC isolates possessing the stx2-NV206 pos-
sessed ehxA (5). Collectively, stx2-subtyping data suggest that
different non-O157 STEC populations predominate in Austra-
lia and France. However, the fact that 134 of 138 (97.1%) of
the Australian stx2-containing STEC isolates and 54 of 130
(41.5%) of the stx2-containing French isolates possessed ehxA
and/or eaeA may bias comparisons between these two STEC
populations. Further studies are required to validate these
hypotheses.
Serotype O113:H21 is increasingly being isolated from pa-
tients with HUS (6, 17, 40) and was the most predominant
serotype in stx2-containing STEC isolates from healthy cattle in
Australia (22a). Studies conducted in France (43), Japan (26),
and Spain (9, 10, 33) all indicated that O113:H21 is among the
most prevalent STEC serotypes recovered from cattle feces.
Furthermore, O113:H21 was identified in 10 of 41 (24.4%)
STEC isolates recovered from a Canadian study of naturally
contaminated beef (3). All of the O113:H21 isolates recovered
in our study (22 bovine and 11 human) were eaeA negative; 29
of 33 (87.9%) possessed the ehxA gene, and only 2 of 33 (6.1%)
possessed stx1. Of 22 (90.9%) bovine isolates of serotype O113:
H21, 20 concomitantly possessed both stx2-EDL933 and stx2vhb
while 2 (9.1%) only possessed stx2vhb. Two O113:H21 isolates
FIG. 1. HaeIII (A) and PvuII (B) digests of PCR products obtained
with VT2-e and VT2-f primers and HincII (C) digests of PCR products
obtained with Lin F and Lin R primers. Lanes: 1, 100-bp Plus marker;
2, stx2d-Ount variant of serotype O91:H
; 3, stx2-EDL933/stx2vhb variant of
serotype O113:H21; 4, stx2-EDL933/stx2vhb variant of serotype O113:H21;
5, stx2-EDL933/stx2vhb variant of serotype O113:H21; 6, stx2-EDL933/stx2vhb
variant of serotype O110:H40; 7, stx2-EDL933 variant of serotype Ont:
H5; 8, stx2vhb variant of serotype Ont:HR; 9, stx2-OX3a variant of sero-
type O5:H; 10, stx2vhb variant of serotype Ont:H11.
FIG. 2. MspI (A), NciI (B), and RsaI (C) digests of PCR products
obtained with Tyler F and Tyler R primers. Lanes: 1, 100-bp Plus
marker; 2, stx2-EDL933/stx2vhb variant of serotype O113:H21; 3, stx2vhb
variant of serotype Ont:HR; 4, stx2-EDL933 variant of serotype Ont:H5;
5, stx2-EDL933 variant of serotype Ont:H5.
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recovered from HUS patients and a third isolate from a patient
with anemia also simultaneously possessed stx2-EDL933 and
stx2vhb. However, four isolates of O113:H21 recovered from
human cases of diarrhea, two from patients with HUS, and one
isolate from an asymptomatic human individual possessed stx2-
EDL933 only. Of the 58 different serotypes identified in our
study, 7 serotypes have been reported to cause HUS (O5:H,
O91:H, O91:H21, O111:H, O111:H8, O157:H7, and O163:
H19).
Ramachandran et al. (44) reported that ovine STEC isolates
that also contain ehxA and/or eaeA predominantly possess stx2d
(stx2d-Ount, stx2d-OX3a, and stx2dO111) subtypes. In contrast, the
cattle STEC isolates described in this study rarely possessed
stx2d subtypes (5 of 138; 3.6%) and three of these isolates
possessed STEC serotypes (O5:H and O91:H) typically
found in sheep. Furthermore, none of the ovine isolates exam-
ined in the study of Ramachandran et al. (44) contained stx2vhb
and only a single isolate possessed stx2EDL933, highlighting a
dramatic contrast with results reported in the present study of
bovine STEC. Bertin et al. (5) showed that 167 bovine stx2-
positive STEC isolates from healthy cattle rarely possessed an
stx2d subtype (8.5% of 167), but their serotype(s) was not
reported. Beutin et al. (8) also found that with the exception of
a single serotype (O90:H24), cattle and sheep differed with
respect to the O:H types of their STEC floras. Together, these
and other studies (14, 22, 22a, 32) suggest that genetically and
serologically different populations of STEC inhabit the gastro-
intestinal tracts of cattle and sheep.
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